Cardiovascular disorders in children with influenza and other acute respiratory viral infections


Ruzhentsova T.A.

1Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being, Moscow, Russia;
Cardiovascular disorders frequently accompany acute respiratory viral infections (ARVI) and influenza in children.
Objective. To estimate the frequency and nature of cardiovascular events in children with ARVI and influenza.
Subjects and methods. The results of a follow-up and examination of 1268 children and adolescents aged 1 to 18 years, who had been hospitalized for various ARVIs of specified etiology, were studied. Examination, and laboratory, electrocardiographic and echocardiographic studies were made.
Results. 118 (9%) children were noted to have a combination of newly identified clinical changes with enhanced activity of cardiac specific enzymes, and disorders revealed by ECG and EchoCG.
Conclusion. Cardiovascular events often develop in children with ARVI and influenza. Their prevention is to use timely adequate etiotropic therapy. Imidazolyl ethanamide pentandiol acid (ingavirin) is a drug with antiviral, anti-inflammatory and immunomodulatory effects, which is recommended to treat ARVI and influenza in children aged 7 years or older.
Keywords: creatine kinase-MB, electrocardiography, transaminases, influenza, acute respiratory viral infections, myocarditis, troponin, echocardiography
Read entire article

Literature

  1. Baranov A.A., Shiljaev R.R., Kaganov B.S. [Selected lectures on pediatrics]. Mosсow: Dinastiya, 2005. 640 p. (In Russ.).
  2. Romantsov M.G., Melnikova I.Yu., Ershov F.I. [Respiratory diseases in sickly children. A guide for doctors.]. Moscow: GEOTAR-Media, 2015. 160 p. (In Russ.).
  3. Kuzmina T.Yu., Tihonova E.P. [Analysis of lethal outcomes for influenza H1N1 Swin]. Prakticheskaya medicina 2011; 3–1(50): 86. (In Russ.).
  4. Svistunova N.V. [Clinical features of modern influenza and a comparative analysis of the effectiveness of antiviral therapy]. Cand. Med. Sci. Moscov, 2014. (In Russ.). http://www.crie.ru/pdf/avtoref1(svistunova). pdf
  5. Finogeev Yu.P., Lobzin Yu.V., Volzhanin V.M., Semena A.V. [Heart disorders in infectious diseases]. St. Petersburg: Foliant, 2003. 251 p. (In Russ.).
  6. Harlamova F.S. [Treatment of acute respiratory viral infections and influenza in often ill children of young age]. Еffektivnaya farmakoterapiya Epidemiologiya i infekcii 2014; 1(24): 14–8. (In Russ.).
  7. Sologub T.V., Ledvanov M.Yu., Malyiy V.P., Stukova N.Yu., Romantsov M.G., Bizenkova M.N., Polyakova T.D. [Flu. Posidrome therapy]. Fundamental’nye issledovaniya 2009; (10): 48–55. (In Russ.).
  8. Azarenok A.A. [The role of the influenza virus and its surface proteins in the development of endothelial dysfunction]. Cand. Biol. Sci. Sankt-Peterburg, 2014. (In Russ.). http://virology.gamaleya.org/download/diser_ azarenok.a.a.pdf
  9. Miromanova N.A., Miromanov A.M. [Markers of endothelial dysfunction in complicated and uncomplicated forms of influenza in children]. Zhurnal infektologii 2016; 4(8): 66–71. (In Russ.).
  10. Pavlov O.N. [The role of infection in pathogenesis of atherogenous inflammatory process]. Klinicist 2013; (1): 9–13. (In Russ.) DOI:10.17650/1818-8338-2013-1-9-13.
  11. Calabrese F., Basso C., Valente M., Thiene G. Coronary thrombosis and sudden death after an enteroviral infection: Case report. APMIS. 2003; 111: 315–8. DOI: 10.1034/j.1600-0463.2003.1110204.x
  12. Kytö V., Saraste A., Saukko P., Henn V., Pulkki K., Vuorinen T., Voipio-Pulkki L.M. Apoptotic cardiomyocyte death in fatal Myocarditis. Am. J. Cardiol. 2004; 94: 746–50. DOI: 10.1016/j.amjcard.2004.05.056
  13. Saraste A., Arola A., Vuorinen T. Kytö V., Kallajoki M., Pulkki K., Voipio-Pulkki L.M., Hyypiä T. Cardiomyocyte apoptosis in experimental coxsackievirus B3 myocarditis. Cardiovasc. Pathol. 2003; 12: 255–62. DOI: 10.1016/s1054-8807(03)00077-2
  14. Caforio A.L., Mahon N.J., Tona F., McKenna W.J. Circulating cardiac autoantibodies in dilated cardiomyopathy and myocarditis: pathogenic and clinical significance. Eur. J. Heart Fail. 2002; (4): 411–7. DOI: 10.1016/s1388-9842(02)00010-7.
  15. Greaves К., Oxford J.S., Price C.P., Clarke G.H., Crake T. The prevalence of myocarditis and skeletal muscle injury during acute viral infection in adults: measurement of cardiac troponins I and T in 152 patients with acute influenza infection. Arch. Intern. Med. 2003; 163: 165–8. DOI: 10.1001/archinte.163.2.165
  16. Mason J.W., Sanjeev T., Renlund D.G. Myocarditis. In: Willerson J.T., Wellens H.J.J., Cohn J.N., Holmes D.R. (eds). Cardiovascular Medicine. 3 ed. London: Springer, 2007; 1: 1313–47. DOI: 10.1007/978-1-84628-715-2_62
  17. Ruzhencova T.A. [Diagnosis and therapy of myocardial lesions in children with acute intestinal infections (clinical and experimental research]. Dr. Med. Sci. Моscow, 2016. (In Russ.). http://www.crie.ru/pdf/avtoref1 (ruzhentsova).pdf
  18. Paleev N.R., Paleev F.N., Sanina N.P., Makarkov A.I., Moskalec O.V., OstrovskyE.I., Hishova N.N. [Heart failure at myocardites and a role of immune mechanisms in its development]. Russkiy medicinskiy zhurnal 2014; (12):878–82. (In Russ.).
  19. Caforio A.L., Pankuweit S., Arbustini E., Basso C., Gimeno-Blanes J., Felix S.B., Fu M., Helio T., Heymans S., Jahns R., Klingel K., Linhart A., Maisch B., McKenna W., Mogensen J., Pinto Y.M., Ristic A., Schultheiss H.P. Current state of knowledge on aetiology, diagnosis, management and therapy of myocarditis. A position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur. Heart J. 2013; 34: 2636–48. DOI: 10.1093/eurheartj/eht210.
  20. D’Ambrosio A., Patti G., Manzoli A., Sinagrab G., Lenardab A.D., Silvestric F., Sciascio G.D. The fate of acute myocarditis between spontaneous improvement and evolution to dilated cardiomyopathy: a review. Heart 2001; 85(5): 499–504. DOI: 10.1136/heart.85.5.499.
  21. Ruzhencova T.A. [Gastroenterological masks of cardiovascular pathology]. Gospitalnaya i klinicheskaya gastroenterologiya 2016; 130(6): 114–17. (In Russ.).
  22. Ruzhencova T.A. [Atypical symptoms of cardiovascular pathology]. Lechashhiy vrach 2017; (3): 75–8. (In Russ.).
  23. Ashaher T., Krohin A., Kuznetsova I., Lengl Y., Nebolsin V., Egorov A., Bergmann M. [Effect of the antiviral drug Ingavirin (imidazolyl ethanamide pentadioic acid) on the interferon status of cells under condition of viral infection]. Epidemiologiya i Infekcionnye Bolezni2016; 21(4): 196–205. (In Russ.). DOI: 10.18821/1560- 9529-2016-21-4-196-205.
  24. Liu P., Mason J.W. Advanced in the understanding of myocarditis. Circulation 2001; 104: 1076–82. DOI: 10.1161/hc3401.095198.
  25. Kolobuhina N.V., Malyishev N.A., Merkulova L.N., Burtseva E.A., Schelkanov M.Yu. [A study of the efficacy and safety of a new antiviral drug in the treatment of patients with influenza]. Russkiy medicinskiy zhurnal 2008; 22: 1502–6. (In Russ.).
  26. Geppe N.A., Teplyakova E.D., Shuldyakov A.A., Lyapina E.P., Perminova O.A., Martyinova G.P., Sitnikov I.G., Anohin V.A., Fatkullina G.R., Romanenko V.V., Savisko A.A., Kondyurina E.G., Balyikova L.A. [Innovations in pediatrics: the optimal clinical effect in acute respiratory viral infections treatment in children with complex action drug]. Pediatriya 2016; 95(2): 96–103. (In Russ.).
  27. Dunn J.J. Identification on the primary genomic determinants of cardiovirulence for clinical coxacievirus B3 isolates. Doctoral thesis; Nebraska, Omaha: University of Nebraska Medical Center, 2000. 235 р.
  28. Matsumori A., Okada I., Yamada T., Maruyama S., Kawai C. Pathogenesis of myocardic injury in myocarditits and cardiomyopathy. Jpn. Circ. J. 1991; 55(11): 1132–7. DOI: 10.1253/jcj.55.1132
  29. Krivosheev B.I., Yaroshenko S.Ya. [Prevention of bacterial complications in respiratory diseases in often and long-term sick children]. Zdorov’e rebenka 2011; 7(34):95–8. (In Russ.).


About the Autors

For correspondence:
Tatiana A. Ruzhentsova, МD, Leading Researcher, Clinical Department of Infectious Pathology, Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being
Address: 3a, Novogireevskaya St., Moscow 111123, Russia
Telephone: +7(495) 672-11-58
E-mail: ruzhencova@gmail.com


Similar Articles

Back to Content

Бионика Медиа